IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of cash flow

(in CHF 1 000)

 

 

Notes

 

01.01.–30.06.2021

 

01.01.–30.06.2020

Cash flows from operating activities

 

 

 

 

 

 

Proceeds from sales of securities

 

4

 

539 046

 

420 021

Purchase of securities

 

4

 

(559 195)

 

(255 787)

Dividend receipts

 

 

 

 

243

Interest receipts

 

 

 

 

7

Payments for services

 

 

 

(29 504)

 

(23 004)

Income taxes paid

 

 

 

(76)

 

(46)

Total cash flows from operating activities

 

 

 

(49 729)

 

141 434

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

Dividend

 

 

 

(199 440)

 

(188 360)

Proceeds from sales of treasury shares

 

6

 

9 398

 

Borrowing of bank loans

 

5

 

237 000

 

47 000

Interest payments

 

 

 

(397)

 

(491)

Total cash flows from financing activities

 

 

 

46 561

 

(141 851)

 

 

 

 

 

 

 

Foreign exchange difference

 

 

 

(474)

 

(4)

Change in cash and cash equivalents

 

 

 

(3 642)

 

(421)

 

 

 

 

 

 

 

Cash and cash equivalents at the beginning of the period

 

 

 

6 816

 

30 707

 

 

 

 

 

 

 

Cash and cash equivalents at the end of the period

 

 

 

3 174

 

30 286

The notes are an integral part of the condensed consolidated interim financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience.Use of cookies & disclaimer